Hormone replacement therapy is important for women, but it must be done properly to minimize risks
*IV Ketamine, NR, and NAD+ have been used clinically off-label for decades. They are not FDA approved for the treatment of any psychiatric or pain condition. All medical treatments carry risks and benefits that you must discuss with a doctor at Clarus Health to learn if these therapies are right for you.

Vivian was the kind of patient every surgeon hopes for—a healthy 58-year-old woman preparing for a routine hip replacement. She told us she wasn't on any medications. The surgery went smoothly, but what happened afterward revealed a dangerous truth about medical culture that every woman needs to understand.
After surgery, Vivian took an unusually long time to wake up—what we call "delayed emergence." At the hospital, she remained deeply lethargic. A brain scan revealed the shocking truth: she'd had a stroke caused by a blood clot that formed during surgery and traveled to her brain.
Blood clots don't commonly occur in routine surgeries. Deep investigation uncovered something Vivian had never disclosed: she was taking oral estrogen.
Vivian made a slow, difficult recovery. When she was finally well enough to speak, we asked about the oral estrogen. Her response broke my heart:
"All my doctors brushed off my questions about hormones, so I went online and ordered HRT"
Despite feeling so much better with balanced hormones, she felt too ashamed to bring it up with her medical team. That fear nearly killed her, because we would have asked her to stop her oral estrogen prior to surgery. Because she was too shy to speak up, she'll never be quite the same.
I'm a strong advocate for hormone balancing—it can be life-changing and life-saving. But it must be done correctly to be safe.
Research consistently shows that hormone replacement therapy increases the risk of blood clots two- to fivefold compared to non-users. However, here's what most patients don't know: the route of administration dramatically affects thrombotic risk.
When estrogen is taken orally, it passes through the liver first, triggering changes in blood clotting factors. Studies demonstrate that oral estrogens increase thrombin generation and induce resistance to activated protein C, while transdermal estrogens (patches, gels, creams) have minimal effects on clotting factors.
The numbers are striking: in one meta-analysis, the risk for blood clots ranged from 60-100% higher for oral estrogen than for transdermal estrogen users.
The risk of thrombosis with oral estrogen becomes dangerously high during surgery, especially orthopedic procedures. The risks of blood clots from orthopedic surgery combine with the risks of blood clots from estrogen hormone replacement therapy.
Vivian's stroke likely could have been prevented if she had been on a transdermal formulation or if she had disclosed her oral estrogen use so it could be discontinued before surgery.
Unfortunately, negative publicity from early hormone studies led many doctors to dismiss women's hormone concerns entirely, leaving patients without adequate guidance. There are many nuances to hormone replacement therapy that your doctor must discuss with you. Unfortunately, many women still face dismissal, though tides are changing with changes in FDA's black box warning labels.
This creates dangerous situations where women:
For most women, transdermal estrogen (patches, gels, or creams) is the safer choice. Even women who have had previous blood clots can often receive estrogen as a skin patch with little-to-no increased risk of blood clots.
Vivian deserved medical providers who took her hormone concerns seriously from the start. She deserved to know that the route of hormone administration could mean the difference between a safe surgery and a life-altering stroke.
Speak with a doctor at Clarus Health today to learn if you are a candidate for bioidentical hormone replacement therapy.